References
- Althuis MD, Scoccia B, Lamb EJ . 2005. Melanoma, thyroid, cervical, and colon cancer risk after use of fertility drugs. American Journal of Obstetrics and Gynecology 193:668–674.
- Brinton LA, Moghissi KS, Scoccia B . 2005. Ovulation induction and cancer risk. Fertility and Sterility 83:261–274.
- Fuller PN. 1999. Malignant melanoma of the ovary and exposure to clomiphene citrate: a case report and review of the literature. American Journal of Obstetrics and Gynecology 180:1499–1503.
- Hannibal CG, Jensen A, Sharif H . 2008. Malignant melanoma risk after exposure to fertility drugs: results from a large Danish cohort study. Cancer Causes and Control 19:759–765.
- Jhaveri MB, Driscoll MS, Grant-Kels JM. 2011. Melanoma in pregnancy. Clinical Obstetrics and Gynecology 54:537–545.
- Kvaskoff M, Bijon A, Mesrine S . 2011. Cutaneous melanoma and endogenous hormonal factors: a large French prospective study. American Journal of Epidemiology 173:1192–1202.
- MacKie RM, Hauschild A, Eggermont AM. 2009. Epidemiology of invasive cutaneous melanoma. Annals of Oncology 20(Suppl 6):1–7.
- McCluggage WG, Bissonnette JP, Young RH. 2006. Primary malignant melanoma of the ovary: a report of 9 definite or probable cases with emphasis on their morphologic diversity and mimicry of other primary and secondary ovarian neoplasms. International Journal of Gynecological Pathology 25:321–329.
- Pentheroudakis G, Orecchia R, Hoekstra HJ . 2010. Cancer, fertility and pregnancy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology 21(Suppl 5):266–273.
- Yli-Kuha AN, Gissler M, Klemetti R . 2012. Cancer morbidity in a cohort of 9175 Finnish women treated for infertility. Human Reproduction 27:1149–1155.